Evaluation of an interactive audiovisual computer program educating patients with rheumatoid arthritis starting treatment with methotrexate: a randomized controlled trial.

• Conditions: Rheumatoid arthritis; Inflammatory and Immune System - Rheumatoid arthritis

• Registration Number: ACTRN12606000072516
• Lead Sponsor: Department of Rheumatology Royal Melbourne Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-02-21
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients with a diagnosis of rheumatoid arthritis based on assessment by a rheumatologist, starting treatment with methotrexate for the first time and attending one of the participating rheumatology centres for follow up.

Exclusion Criteria

Patients will be excluded if they are non English speaking and/or reading, are hearing or visually impaired to a degree that would preclude use of the computer program or are unlikly to comply with follow up.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient knowledge assessed using a questionnaire[At 6 weeks, 3 months and 6 months post commencement of methotrexate.]

Secondary Outcome Measures

Name	Time	Method
Health assessment questionnaire (HAQ) and pain score[Assessed at 6 weeks, 3 months and 6 months.];Rheumatoid arthritis self-efficacy scale (RASE)[Assessed at 6 weeks, 3 months and 6 months.];Assessment of quality of life (AQoL)[Assessed at 6 weeks, 3 months and 6 months.];Spielberger state and trait anxiety scale (STAI)[Assessed at 6 weeks, 3 months and 6 months.];Kessler psychological distress scale[Assessed at 6 weeks, 3 months and 6 months.];Methotrexate related adverse events[Assessed at 6 weeks, 3 months and 6 months.];Treatment cessation or failure and compliance.[Assessed at 6 weeks, 3 months and 6 months.]